Skip to content

The Study of Pain Allergy Induced by Eschloramine in diabetes Based on G9a Protein Signal Pathway

The Study of Pain Allergy Induced by Eschloramine in diabetes Based on G9a Protein Signal Pathway

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500102141
Enrollment
Unknown
Registered
2025-05-09
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic neuropathic pain

Interventions

Group E1:After the patient was admitted to the room, the sacral plexus nerve block was given under ultrasound guidance, and after the successful block, the E1 group was given a single intravenous admi
Group E2:The patient was given sacral plexus nerve block under ultrasound guidance after admission, and after successful block, E2 group was given a single intravenous administration of esketamine 0.5
Group N:After entering the room, the patient was given sacral plexus nerve block under ultrasound guidance, and after successful block, group N was given a single intravenous saline of 10ml.

Sponsors

Zhu Xianyi Memorial Hospital, Tianjin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Diabetic foot debridement is planned to be performed under nerve block anesthesia with a clear diagnosis of diabetic foot and NP; (2) Age >=18 years old, gender is not limited; (3) ASA classification II.-III; (4) The patient is informed and voluntarily joins and signs the consent form.

Exclusion criteria

Exclusion criteria: (1) Patients who do not meet the inclusion criteria; (2) Patients with contraindications to ketamine, including impaired consciousness, neuropsychiatric history, severe cardiovascular history, poorly controlled or untreated hypertension or hyperthyroidism, pregnancy or lactation; (3) Those who have a known history of severe allergies and family history or are allergic to ketamine; (4) Those who have used non-steroidal anti-inflammatory drugs or opioid analgesics within 48 hours before surgery; (5) Patients or their family members who refuse to participate in the study and whose data are incomplete.

Design outcomes

Primary

MeasureTime frame
Mechanical pain threshold;

Secondary

MeasureTime frame
The onset time and duration of sensation and motor block;Postoperative recovery quality;Patient pain score;Intraoperative hemodynamic indicators of patients;General information of the patient (age, gender, weight, BMI, ASA grading, underlying diseases);

Countries

China

Contacts

Public ContactJing Gong

Zhu Xianyi Memorial Hospital, Tianjin Medical University

gonngjing19868@163.com+86 180 0200 2580

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026